{"id":5042,"date":"2022-02-22T00:00:00","date_gmt":"2022-10-14T16:15:19","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/"},"modified":"2023-05-02T08:29:12","modified_gmt":"2023-05-02T12:29:12","slug":"eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/","title":{"rendered":"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2"},"content":{"rendered":"<p>Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques \u00e0 l\u2019appui des recommandations de surveillance de la glyc\u00e9mie et des consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie. L\u2019objectif de ce module est d\u2019appuyer l\u2019utilisation des donn\u00e9es de surveillance continue de la glyc\u00e9mie (SCG) dans la pratique au quotidien, en rehaussant la confiance des pharmaciens lorsqu\u2019ils conseillent et renseignent les personnes qui b\u00e9n\u00e9ficieraient de la SCG.<\/p>\n<hr>\n<p>Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de Abbott, de Janssen et de Novo Nordisk<\/p>","protected":false},"featured_media":440765,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-5042","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques \u00e0 l\u2019appui des recommandations de surveillance de la glyc\u00e9mie et des consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie. L\u2019objectif de ce module est d\u2019appuyer l\u2019utilisation des donn\u00e9es de surveillance continue de la glyc\u00e9mie (SCG) dans la pratique au quotidien, en [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:29:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/\",\"name\":\"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg\",\"datePublished\":\"2022-10-14T16:15:19+00:00\",\"dateModified\":\"2023-05-02T12:29:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/","og_locale":"fr_CA","og_type":"article","og_title":"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase","og_description":"Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques \u00e0 l\u2019appui des recommandations de surveillance de la glyc\u00e9mie et des consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie. L\u2019objectif de ce module est d\u2019appuyer l\u2019utilisation des donn\u00e9es de surveillance continue de la glyc\u00e9mie (SCG) dans la pratique au quotidien, en [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:29:12+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/","url":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/","name":"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2 - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg","datePublished":"2022-10-14T16:15:19+00:00","dateModified":"2023-05-02T12:29:12+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Glucose-Monitoring-Hypoglycemia-Type2-Diabetes-1324060130-600-20.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-3-recommandations-pour-la-surveillance-de-la-glycemie-et-considerations-a-legard-de-lhypoglycemie-chez-les-personnes-atteintes-de-diabete-de-type-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Eb 3 : Recommandations pour la surveillance de la glyc\u00e9mie et consid\u00e9rations \u00e0 l\u2019\u00e9gard de l\u2019hypoglyc\u00e9mie chez les personnes atteintes de diab\u00e8te de type 2"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=5042"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/440765"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=5042"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=5042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}